Karo Healthcare’s Post

CGBIO achieved record-breaking sales in 2023, with a revenue of 156.7 billion KRW and a business profit of 20.4 billion KRW. This marks an impressive increase of 20.8% in revenue and 12% in operating profit compared to the previous year, nearly doubling its growth over the past three years.   Steady growth in the regenerative medicine market and CGBIO’s strategy to expand globally have contributed to consistent revenue growth. Our key growth drivers, Novosis(bone graft substitute) and filler product line, also saw significant growth of 30% and 127% respectively compared to the previous year.   CGBIO plans to continue strengthening its product capabilities and developing new businesses to sustain growth even in 2025. The company aims to expand its export markets and establish a dental business division, focusing on securing future growth drivers.   ➡For full article: https://lnkd.in/gZW9-bwS #CGBIO #NOVOSIS #NOVOSISPUTTY #BDD #FDA #FACETEM #CEDERM #filler #RegenerativeMedicine #spine #implant #stemcell #global

Have you ever tried to ask chatGPT what are the #criticalissues of the process in between an #autocalve and the #isolator? I did it! … and here is the reply: “One of the primary challenges is mantaining sterility throughout the transfer. Autoclaves are designed to sterilize equipment and materials through high-pressure saturated steam, effectively eliminating microbial life. However, once sterilization cycle is complete, transferring these sterile items into an isolator without compromising their #sterility requires meticulous #planning and #execution.” But how to plan and execute a safe transfer only Simone Riva and alessandra benassi can tell! Don’t miss the today’s Fedegari Group and IMA Group co-speech at PDA Italy Chapter event! #sterilizationbydesign #WeAreFedegari

Who’s coming to Dortmund??? I can’t hide my excitement for this year’s CB Expo and InterTabac - InterSupply B2B from the 14th to 16th of September! DéWarrior Unlimited B.V. has a few things cooking that we’re quite proud of: 🥦 Anthony Shevlin, the man the myth the legend, broccoli breeder extraordinaire will take part in a genetics panel and master class on why this topic is mission critical for LPs. ☢️ Spyro Michalopoulos will present the culmination of nearly 2 years worth of research to illustrate that Rad Source Technologies may be the most viable in-house alternative to gamma and e-beam irradiation for pharmaceutical products. 😎I’ll be moderating a panel of ABSOLUTE heavy hitters and industry Trail Blazers on the importance of non-financial KPI’s in saturating markets… can’t wait to announce the fantastic-4 who have already confirmed and there’s one more spot I offered up that I’m 🤞 to confirm by Monday! This panel comes straight out of DéWarrior Unlimited B.V. Day-to-day work and it’s an honor to bring this conversation to wider audiences. Discount code attached below for your savings pleasure. Hit me up if you have any questions and can’t wait to connect in #dortmund! #cannabis #cannabisindustry #pharmaceutical #eugmp #apidevelopment #vc #germany

Head over to stand 161 at Drug Delivery to the Lungs Conference (DDL) in Edinburgh to meet with CEO David Wyatt, Development Director Jasdip Koner and Business Development Manager Abdul Ershad who are keen to discuss our latest and most unique formulation innovation in the respiratory and nasal delivery sector as well as what partnership opportunities with APT might look like. Our poster will be presented at DDL 2023, alongside another collaborative poster with Nanopharm Ltd, an Aptar Pharma Company. ➡Poster 1: Investigating the Dispersion Capability of High Dose DPI Formulations Manufactured Through Isothermal Dry Particle Coating (iDPC™) - Rhys Jones, Amandip Gill, David Wyatt, AfzalRahman Mohammed, and Jasdip Koner.   ➡Poster 2: Assessment of the Automatic Filling of Orbital™ Device Loaded with a Model Fluticasone Propionate Blend Manufactured by Isothermal Dry Particle Coating - Cristina Rey Blanes, Reanne Beaird, Norma Ulrich, Katarzyna Epeslidis, Niall Doherty, Will Ganley, Jonathan Tournaire, Jasdip Koner, Rhys Jones, Andrea Silvestri and Irene Rossi. Here at APT we are committed to providing the expertise to ensure the highest quality formulation and manufacture for the successful development of your dry powder inhaled therapies and products. We’re looking forward to some great discussions and hope to catch-up with you across the 3-day event from the 6th to 8th December whether you’re new contacts or familiar faces, friends and partners. Visit our website: https://lnkd.in/eZ4Dh72b Read our article published in ONdrugDelivery: https://lnkd.in/eZ3g7ehC  #DDL2023 #drugdeliverytothelungs #respiratory #pulmonary #inhalation #drugdevelopment #powdermixing #nasal #pharma #iDPC #APT #OINDP #thinlayerfluidisation #isothermaldryparticlecoating #drypowders #powderflow #drugdelivery #formulation #reformulation #repurposing #generic #ANDA #capsule #drypowderinhaler #DPI #inhaleddrug #collaboration #manufacturing #licensing #productdevelopment #acceleratedevelopment #innovation #networking

Pluumo underwent rigorous testing in extreme conditions of a constant 30°C — a testament to Pluumo’s dedication to excellence in thermal protection for temperature-sensitive products. 🌡️💼   Keep an eye on Pluumo as we redefine resilience and sustainability in #coldchain logistics. 🚀   Stay tuned for some exiting updates! 👀   #pharmalogistics #thermalpackaging #PluumoInnovation

Glenmark, Alphamab deal worth up to $700M; Tourmaline’s $150M offering; Repare records $40M milestone >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #pharmaceutical #biotech #healthcare #productmarketing

In the News: Arovella Therapeutics takes key manufacturing step on ALA-101’s path to clinic 🌟 Discover the latest in the world of FDI and Business! Check out this insightful piece. 💡🌍 Arovella Therapeutics Ltd (ASX:ALA) has completed a key manufacturing step to progress lead product ALA-101 to clinic with its Good Manufacturing Practice... 🔗 [Learn more: https://lnkd.in/gx8twCxa] 🗨️ Join the Discussion! Your opinions are invaluable. #Comment below to share your views, ask questions, or start a conversation. We're excited to engage with each comment and hear what you think! Join as a Partner and Professional: FDI Alliance: www.fdialliance.com Valqus Accounting and Business: www.valqus.com #FDI #Invest #Trade #TradeandInvest #InvestmentPromotion #Markets #Business #Accounting

Thank you to everyone who attended ACHEMA 2024 in Frankfurt. We were delighted to witness the significant interest and excitement surrounding our tablet counting technology. 📽 Here are some highlights from our valued partner, TECNOMACO ITALIA. 🙌 We deeply appreciate the wonderful hospitality; connecting with the entire team was fantastic. Carlo Federici Tommaso Serafini Federico Romano Valeria Altarocca #tabletcounter #tablet #capsule #capsulecouter #automation #pharma #ACHEMA #tabletcounting #machinary #innovationtechnology #datadetectiontechnologies #visioncounting #automation #accuracy #counting #primarypackaging #packagingmachinery #packagingindustry #engineering #pharmaceuticalpackaging #pharmaceuticalmanufacturing #pharmaceuticalindustry #nutraceuticals #supplements